[Form 4] SCHWAB CHARLES CORP Insider Trading Activity
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Charles Schwab’s MD and Chief Banking Officer Paul V. Woolway reported a mix of equity awards, option activity, and insider sales in company stock. Across several open-market transactions executed through a trust, he sold 22,010 shares of common stock, with prices in the mid‑$90s, under a pre‑arranged Rule 10b5‑1 trading plan. The filing also shows shares acquired from vesting of performance-based restricted stock units tied to a three-year goal period ending December 31, 2025, the exercise of a nonqualified stock option, a new stock option grant, and shares withheld to cover related tax obligations.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 22,010 shares ($2,090,390)
Net Sell
12 txns
Insider
Woolway Paul V
Role
MD, Chief Banking Officer
Sold
22,010 shs ($2.09M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 3,626 | $94.4144 | $342K |
| Sale | Common Stock | 2,500 | $94.8904 | $237K |
| Exercise | Nonqualified Stock Option (right to buy) | 15,884 | $0.00 | -- |
| Grant/Award | Nonqualified Stock Option (right to buy) | 15,189 | $0.00 | -- |
| Exercise | Common Stock | 15,884 | $52.05 | $827K |
| Sale | Common Stock | 7,942 | $94.23 | $748K |
| Sale | Common Stock | 7,942 | $96.0013 | $762K |
| Grant/Award | Common Stock | 8,156 | $0.00 | -- |
| Tax Withholding | Common Stock | 2,030 | $90.305 | $183K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 32,366.437 shares (Indirect, by Trust);
Nonqualified Stock Option (right to buy) — 15,883 shares (Direct);
Common Stock — 25,153 shares (Direct)
Footnotes (1)
- Shares acquired on the vesting of performance-based restricted stock units ("PBRSUs") granted under the company's 2022 Stock Incentive Plan, reflecting the achievement by the reporting person of the performance goal over a three-year performance period ended December 31, 2025. The company withheld shares of common stock from the reporting person to pay the tax withholding obligations related to the vesting of the PBRSUs. Reflects the contribution of 15,884 shares received upon exercise of the options to a revocable trust. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-l trading plan adopted by the reporting person on November 24, 2025. This transaction was executed in multiple trades at prices ranging from $96.00 to $96.01. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $93.7 to $94.695. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected. This transaction was executed in multiple trades at prices ranging from $94.72 to $95.07. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected. The option was granted under the company's 2013 Stock Incentive Plan and vested in four equal annual installments beginning on the first anniversary of the grant date. The option was granted under the company's 2022 Stock Incentive Plan and vests in four equal annual installments beginning on the first anniversary of the grant date.
